Myovant Sciences Ltd. MYOV
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.62B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -26.19
- Beta
- 2.15
- Short ratio
- 11.21
- Inst. own
- 56.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 26, 2023
- 50-d avg
- 26.92
- 200-d avg
- 21.54
- 1y target
- 27.00
Discussion (17)
Sign in to join the discussion
FDA Approval came in late today. I guess most people are not aware of it.
Myovant Sciences' (MYOV) ORGOVYX approved by FDA for treatment of adult patients with advanced prostate cancer
December 18, 2020 12:05 PM
Myovant Sciences' (NYSE: MYOV) ORGOVYX approved by FDA for treatment of adult patients with advanced prostate cancer
The PDF could not be displayed inside the page,
another piece of garbage as ZSNO and SELB, all downs for technical issues, it wont recover, it is sinking
strong support on $14, all depend now on Thursday PM sentiment, market could turn red tomorrow on jobless claim news for the week since big companies as Disney are announcing huge layoffs, i am hoping a little bounce up after this unreasonable oversold today, company fundamentals are solid and positive, it should go up!!!
If we break 14.40 we open at 15.35..
Still holding full from 10.69 see what she got this morning...
10.69 avg holding small but holding...
All in..
We hit 15+ tonight then to 21 tomorrow premarket open..
Flying high now wow..
She gone...